SB-236057 is used as a 5-HT1B receptor inverse agonist to study its effects on embryonic development, particularly in investigating Notch signaling pathway disruption, gene expression alterations via interaction with r-esp1, and induction of somite patterning and caudal extension defects during early organogenesis in rat embryos.